Failure to develop neutralizing antibodies following SARS-CoV-2 infection in young patients with inflammatory bowel disease receiving biologics

Authors
Category Primary study
JournalJ. Pediatr. Gastroenterol. Nutr.
Year 2021
This article has no abstract
Epistemonikos ID: c1b057ef3bf4ed732e0595795fd9d8101fa1f3fb
First added on: Jun 15, 2021